Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Reprogramming of mitochondrial metabolism by innate immunity.

Garaude J.

Curr Opin Immunol. 2019 Feb;56:17-23. doi: 10.1016/j.coi.2018.09.010. Epub 2018 Oct 1. Review.

PMID:
30286442
2.

How Mitochondrial Metabolism Contributes to Macrophage Phenotype and Functions.

Benmoussa K, Garaude J, Acín-Pérez R.

J Mol Biol. 2018 Oct 19;430(21):3906-3921. doi: 10.1016/j.jmb.2018.07.003. Epub 2018 Jul 10. Review.

PMID:
30006265
3.

Priming of dendritic cells by DNA-containing extracellular vesicles from activated T cells through antigen-driven contacts.

Torralba D, Baixauli F, Villarroya-Beltri C, Fernández-Delgado I, Latorre-Pellicer A, Acín-Pérez R, Martín-Cófreces NB, Jaso-Tamame ÁL, Iborra S, Jorge I, González-Aseguinolaza G, Garaude J, Vicente-Manzanares M, Enríquez JA, Mittelbrunn M, Sánchez-Madrid F.

Nat Commun. 2018 Jul 9;9(1):2658. doi: 10.1038/s41467-018-05077-9.

4.

Mitochondrial Complex I activity signals antioxidant response through ERK5.

Khan AUH, Allende-Vega N, Gitenay D, Garaude J, Vo DN, Belkhala S, Gerbal-Chaloin S, Gondeau C, Daujat-Chavanieu M, Delettre C, Orecchioni S, Talarico G, Bertolini F, Anel A, Cuezva JM, Enriquez JA, Cartron G, Lecellier CH, Hernandez J, Villalba M.

Sci Rep. 2018 May 9;8(1):7420. doi: 10.1038/s41598-018-23884-4.

5.

The mitochondrial respiratory chain: A metabolic rheostat of innate immune cell-mediated antibacterial responses.

Sander LE, Garaude J.

Mitochondrion. 2018 Jul;41:28-36. doi: 10.1016/j.mito.2017.10.008. Epub 2017 Oct 18. Review.

6.

Innate Immune Function of Mitochondrial Metabolism.

Sancho D, Enamorado M, Garaude J.

Front Immunol. 2017 May 8;8:527. doi: 10.3389/fimmu.2017.00527. eCollection 2017. Review.

7.

Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense.

Garaude J, Acín-Pérez R, Martínez-Cano S, Enamorado M, Ugolini M, Nistal-Villán E, Hervás-Stubbs S, Pelegrín P, Sander LE, Enríquez JA, Sancho D.

Nat Immunol. 2016 Sep;17(9):1037-1045. doi: 10.1038/ni.3509. Epub 2016 Jun 27.

8.

IFNα signaling through PKC-θ is essential for antitumor NK cell function.

Comet NR, Aguiló JI, Rathoré MG, Catalán E, Garaude J, Uzé G, Naval J, Pardo J, Villalba M, Anel A.

Oncoimmunology. 2014 Nov 14;3(8):e948705. eCollection 2014.

9.

[Control of innate immune system for cancer therapy].

Garaude J.

Med Sci (Paris). 2013 Nov;29(11):985-90. doi: 10.1051/medsci/20132911014. Epub 2013 Nov 20. Review. French.

10.

"Flagellated" cancer cells propel anti-tumor immunity.

Garaude J, Blander JM.

Oncoimmunology. 2012 Sep 1;1(6):940-942.

11.

The protooncogene Vav1 regulates murine leukemia virus-induced T-cell leukemogenesis.

Kaminski S, Adjali O, Jacquet C, Garaude J, Keriel A, Lassaux A, Hipskind R, Sitbon M, Taylor N, Villalba M.

Oncoimmunology. 2012 Aug 1;1(5):600-608.

12.

Protein Kinase C-θ (PKC-θ) in Natural Killer Cell Function and Anti-Tumor Immunity.

Anel A, Aguiló JI, Catalán E, Garaude J, Rathore MG, Pardo J, Villalba M.

Front Immunol. 2012 Jul 5;3:187. doi: 10.3389/fimmu.2012.00187. eCollection 2012.

13.

Attacking tumor cells with a dual ligand for innate immune receptors.

Garaude J, Blander JM.

Oncotarget. 2012 Apr;3(4):361-2. No abstract available.

14.

From tumor cell metabolism to tumor immune escape.

Villalba M, Rathore MG, Lopez-Royuela N, Krzywinska E, Garaude J, Allende-Vega N.

Int J Biochem Cell Biol. 2013 Jan;45(1):106-13. doi: 10.1016/j.biocel.2012.04.024. Epub 2012 May 5. Review.

15.

Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses.

Garaude J, Kent A, van Rooijen N, Blander JM.

Sci Transl Med. 2012 Feb 8;4(120):120ra16. doi: 10.1126/scitranslmed.3002868.

16.

ICOStomizing immunotherapies with T(H)17.

Garaude J, Blander JM.

Sci Transl Med. 2010 Oct 27;2(55):55ps52. doi: 10.1126/scitranslmed.3001722.

PMID:
20980694
17.

Infection and apoptosis as a combined inflammatory trigger.

Torchinsky MB, Garaude J, Blander JM.

Curr Opin Immunol. 2010 Feb;22(1):55-62. doi: 10.1016/j.coi.2010.01.003. Review.

18.

ERK5 knockdown generates mouse leukemia cells with low MHC class I levels that activate NK cells and block tumorigenesis.

Charni S, Aguilo JI, Garaude J, de Bettignies G, Jacquet C, Hipskind RA, Singer D, Anel A, Villalba M.

J Immunol. 2009 Mar 15;182(6):3398-405. doi: 10.4049/jimmunol.0803006.

19.

Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation.

Torchinsky MB, Garaude J, Martin AP, Blander JM.

Nature. 2009 Mar 5;458(7234):78-82. doi: 10.1038/nature07781.

PMID:
19262671
20.

Protein kinase C-theta is required for NK cell activation and in vivo control of tumor progression.

Aguiló JI, Garaude J, Pardo J, Villalba M, Anel A.

J Immunol. 2009 Feb 15;182(4):1972-81. doi: 10.4049/jimmunol.0801820.

21.

Impaired anti-leukemic immune response in PKCtheta-deficient mice.

Garaude J, Kaminski S, Charni S, Aguilò JI, Jacquet C, Plays M, Hernandez J, Rodriguez F, Hipskind RA, Anel A, Villalba M.

Mol Immunol. 2008 Jul;45(12):3463-9. doi: 10.1016/j.molimm.2008.03.016. Epub 2008 May 6.

PMID:
18462800
22.

SUMOylation regulates the transcriptional activity of JunB in T lymphocytes.

Garaude J, Farrás R, Bossis G, Charni S, Piechaczyk M, Hipskind RA, Villalba M.

J Immunol. 2008 May 1;180(9):5983-90.

23.

ERK5 activates NF-kappaB in leukemic T cells and is essential for their growth in vivo.

Garaude J, Cherni S, Kaminski S, Delepine E, Chable-Bessia C, Benkirane M, Borges J, Pandiella A, Iñiguez MA, Fresno M, Hipskind RA, Villalba M.

J Immunol. 2006 Dec 1;177(11):7607-17.

24.

The role of ERK5 in T-cell signalling.

Garaude J, Kaminski S, Cherni S, Hipskind RA, Villalba M.

Scand J Immunol. 2005 Dec;62(6):515-20.

Supplemental Content

Loading ...
Support Center